Literature DB >> 28640434

Catechol-O-Methyltransferase Genotype and Gait Speed Changes over 10 Years in Older Adults.

Andrea L Metti1, Caterina Rosano1, Robert Boudreau1, Robyn Massa2, Kristine Yaffe3,4,5, Suzanne Satterfield6, Tamara Harris7, Andrea L Rosso1.   

Abstract

OBJECTIVES: To determine the association between catechol-O-methyltransferase (COMT) genotype and 6-m walk time and to determine whether these associations are quadratic in nature, similar to previously reported U-shaped associations between dopamine and gait and cognition.
DESIGN: Prospective cohort study.
SETTING: Health, Aging and Body Composition Study. PARTICIPANTS: Black (n = 850) and white (n = 1,352) men and women with a mean age of 73.5 ± 2.85 at baseline. MEASUREMENTS: Mixed models were used to assess the association between the COMT genotype and 6-m walk time, cross-sectionally and longitudinally over 10 years. Models were assessed unstratified and stratified according to race because allele distributions were different between white and black participants.
RESULTS: There was a significant U-shaped association between COMT genotype and 6-m walk time: those with higher (Val/Val) and lower (Met/Met) dopamine slowed more over 10 years (0.22 ± 0.02 seconds per visit and 0.23 ± 0.02 seconds per visit, respectively) than those with the intermediate (Met/Val) dopamine (0.20 ± 0.02 seconds per visit) (P = .005). Stratified results showed a significant relationship in black (P = .01) but not white (P = .15) participants.
CONCLUSION: These findings indicate a role of dopaminergic regulation of gait speed in community-dwelling older adults and of prefrontal cortex involvement in gait performance. Future work should investigate the molecular integrity of dopaminergic networks and gait changes over time and structural changes in the brain with COMT and gait decline in older adults.
© 2017, Copyright the Authors Journal compilation © 2017, The American Geriatrics Society.

Entities:  

Keywords:  aging; catechol-O-methyltransferase; dopamine; mobility disability; physical function

Mesh:

Substances:

Year:  2017        PMID: 28640434      PMCID: PMC5603384          DOI: 10.1111/jgs.14980

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  42 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

3.  Multisystem physiologic impairments and changes in gait speed of older adults.

Authors:  Andrea L Rosso; Jason L Sanders; Alice M Arnold; Robert M Boudreau; Calvin H Hirsch; Michelle C Carlson; Caterina Rosano; Stephen B Kritchevsky; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-11-07       Impact factor: 6.053

4.  Transcranial direct current stimulation reduces the cost of performing a cognitive task on gait and postural control.

Authors:  Junhong Zhou; Ying Hao; Ye Wang; Azizah Jor'dan; Alvaro Pascual-Leone; Jue Zhang; Jing Fang; Brad Manor
Journal:  Eur J Neurosci       Date:  2014-01-20       Impact factor: 3.386

5.  Age-related striatal dopaminergic denervation and severity of a slip perturbation.

Authors:  Rakié Cham; Subashan Perera; Stephanie A Studenski; Nicolaas I Bohnen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-11       Impact factor: 6.053

6.  Effect of catechol-O-methyltransferase val158met genotype on attentional control.

Authors:  Giuseppe Blasi; Venkata S Mattay; Alessandro Bertolino; Brita Elvevåg; Joseph H Callicott; Saumitra Das; Bhaskar S Kolachana; Michael F Egan; Terry E Goldberg; Daniel R Weinberger
Journal:  J Neurosci       Date:  2005-05-18       Impact factor: 6.167

Review 7.  The correlative triad among aging, dopamine, and cognition: current status and future prospects.

Authors:  Lars Bäckman; Lars Nyberg; Ulman Lindenberger; Shu-Chen Li; Lars Farde
Journal:  Neurosci Biobehav Rev       Date:  2006-08-09       Impact factor: 8.989

8.  Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels.

Authors:  David Reich; Nick Patterson; Vijaya Ramesh; Philip L De Jager; Gavin J McDonald; Arti Tandon; Edwin Choy; Donglei Hu; Bani Tamraz; Ludmila Pawlikowska; Christina Wassel-Fyr; Scott Huntsman; Alicja Waliszewska; Elizabeth Rossin; Rongling Li; Melissa Garcia; Alexander Reiner; Robert Ferrell; Steve Cummings; Pui-Yan Kwok; Tamara Harris; Joseph M Zmuda; Elad Ziv
Journal:  Am J Hum Genet       Date:  2007-03-08       Impact factor: 11.025

9.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 10.  The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.

Authors:  Robert M Bilder; Jan Volavka; Herbert M Lachman; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

View more
  10 in total

1.  Influence of Striatal Dopamine, Cerebral Small Vessel Disease, and Other Risk Factors on Age-Related Parkinsonian Motor Signs.

Authors:  Caterina Rosano; Andrea L Metti; Andrea L Rosso; Stephanie Studenski; Nicolaas I Bohnen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-03-09       Impact factor: 6.053

2.  Is impaired dopaminergic function associated with mobility capacity in older adults?

Authors:  Simon Moskowitz; David W Russ; Leatha A Clark; Nathan P Wages; Dustin R Grooms; Adam J Woods; Julie Suhr; Janet E Simon; Andrew O'Shea; Cody R Criss; Paolo Fadda; Brian C Clark
Journal:  Geroscience       Date:  2020-11-24       Impact factor: 7.713

3.  Associations of Usual Pace and Complex Task Gait Speeds With Incident Mobility Disability.

Authors:  Andrea L Rosso; Andrea L Metti; Kimberly Faulkner; Jennifer S Brach; Stephanie A Studenski; Mark Redfern; Caterina Rosano
Journal:  J Am Geriatr Soc       Date:  2019-07-18       Impact factor: 5.562

4.  Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls.

Authors:  Andrea L Rosso; Zachary A Marcum; Xiaonan Zhu; Nicolaas Bohnen; Caterina Rosano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-05-05       Impact factor: 6.591

5.  Catechol-O-Methyltransferase Genotype, Frailty, and Gait Speed in a Biracial Cohort of Older Adults.

Authors:  Shannon Mance; Andrea Rosso; Joshua Bis; Stephanie Studenski; Nico Bohnen; Caterina Rosano
Journal:  J Am Geriatr Soc       Date:  2020-10-12       Impact factor: 5.562

6.  Sarcopenia and Neuroscience: Learning to Communicate.

Authors:  Brian C Clark; Richard G Carson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-09-13       Impact factor: 6.053

7.  Identification of a Novel Locus for Gait Speed Decline With Aging: The Long Life Family Study.

Authors:  Adam J Santanasto; Mary K Wojczynski; Ryan K Cvejkus; Shiow Lin; Lihua Wang; Bharat Thyagarajan; Kaare Christensen; Nicole Schupf; Mary F Feitosa; Ping An; Joseph M Zmuda
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-09-13       Impact factor: 6.591

8.  Catechol-O-methyltransferase (COMT) polymorphism predicts rapid gait speed changes in healthy older adults.

Authors:  Briana N Sprague; Andrea L Rosso; Xiaonan Zhu; Nicolaas I Bohnen; Caterina Rosano
Journal:  J Am Geriatr Soc       Date:  2021-07-06       Impact factor: 5.562

9.  The Aging Brain & the Dorsal Basal Ganglia: Implications for Age-Related Limitations of Mobility.

Authors:  Brian C Clark; Adam J Woods; Leatha A Clark; Cody R Criss; Reza Shadmehr; Dustin R Grooms
Journal:  Adv Geriatr Med Res       Date:  2019-08-16

10.  Vascular and dopaminergic contributors to mild parkinsonian signs in older adults.

Authors:  Andrea L Rosso; Nicolaas I Bohnen; Lenore J Launer; Howard J Aizenstein; Kristine Yaffe; Caterina Rosano
Journal:  Neurology       Date:  2017-12-15       Impact factor: 9.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.